| -0.41 / -0.91%|
Lannett Co., Inc. develops, manufactures, markets and distributes generic versions of pharmaceutical products. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations. It manufactures solid oral dosage forms, including tablets and capsules, topical and oral solutions, and is pursuing partnerships and research contracts for the development and production of other dosage forms, including ophthalmic, nasal and injectable products. The company was founded in 1942 and is headquartered in Philadelphia, PA.
|Arthur P. Bedrosian||CEO, Director & Head-Investor Relations|
|Michael J. Bogda||President|
|William F. Schreck||Chief Operating Officer|
|Martin P. Galvan||Chief Financial Officer, Treasurer & VP|
|Robert Ehlinger||Chief Information Officer & VP-logistics|